DVAX Stock Balance Sheets

Dynavax Technologies Quarterly Balance Sheets Chart

Quarterly

Annual

Goodwill

Cash and Cash Eq

Account Payables

Deferred Revenue

Inventory

Dynavax Technologies Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30

assets
current assets:
cash and cash equivalents	99,101,000	51,720,000	95,883,000	119,332,000	112,501,000	132,033,000	150,279,000	154,511,000	226,823,000	174,350,000	202,004,000	198,576,000	249,091,000	179,421,000	436,189,000	246,351,000	129,608,000	79,055,000	32,073,000	32,688,000	60,485,000	37,899,000	39,884,000	37,297,000	34,225,000	112,133,000	49,348,000	38,712,000	28,726,000	36,067,000	26,584,000	20,096,000	37,675,000	21,472,000	24,289,000	23,021,000	24,787,000	38,858,000	44,812,000	103,031,000	36,486,000	14,713,000	49,511,000	19,656,000	17,032,000	26,750,000	23,122,000	12,191,000	17,585,000	25,016,000	7,599,000	24,650,000	34,530,000	19,753,000	31,941,000	19,072,000	27,479,000	20,971,000	22,453,000	28,209,000	29,053,000	30,080,000	36,720,000	24,735,000	23,759,000	22,920,000	28,103,000	22,618,000	14,870,000	15,858,000	14,293,000	14,642,000	6,503,000	12,979,000	14,154,000	15,951,000	10,090,000	16,842,000	8,725,000	19,168,000	5,116,000	11,401,000	16,590,000	71,514,000	73,959,000
marketable securities available-for-sale	514,628,000	609,616,000	617,951,000	644,660,000	623,111,000	591,505,000	592,023,000	565,905,000	454,702,000	477,606,000	422,391,000	387,910,000	269,078,000	323,795,000	109,761,000	167,804,000	216,196,000	153,619,000	132,963,000	144,473,000	140,223,000	91,634,000	111,171,000	137,649,000	106,269,000	71,083,000	96,188,000	141,509,000	187,317,000	214,713,000	165,270,000	171,584,000	89,286,000	63,884,000	57,126,000	86,530,000	114,202,000	127,989,000	151,313,000	117,666,000	56,895,000	82,881,000	73,141,000	110,916,000	137,281,000	150,929,000	166,254,000	64,283,000	71,576,000	80,357,000	117,531,000	123,629,000	125,669,000	87,128,000														14,958,000	20,216,000	27,828,000		21,279,000	40,977,000	49,744,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at june 30, 2025 and december 31, 2024, respectively	70,699,000
other receivables	2,646,000	1,632,000	1,625,000	1,943,000	976,000	1,993,000	3,926,000	519,000	2,108,000	3,128,000	2,385,000	1,346,000	1,972,000	2,968,000	15,600,000
inventories	75,687,000	74,403,000	70,054,000	62,402,000	62,462,000	61,806,000	53,290,000	49,412,000	53,088,000	57,693,000	59,446,000	102,609,000	73,979,000	79,038,000	61,335,000	67,297,000	86,451,000	68,846,000	63,689,000	59,033,000	54,392,000	48,099,000	41,332,000	39,356,000	36,629,000	27,569,000	19,022,000	12,452,000	5,112,000	550,000	312,000
prepaid expenses and other current assets	22,951,000	23,674,000	18,147,000	24,570,000	21,308,000	19,788,000	18,995,000	18,972,000	17,494,000	15,626,000	85,629,000	100,004,000	134,538,000	82,995,000	73,764,000	61,093,000	9,453,000	9,377,000	9,206,000	18,786,000	9,463,000	8,380,000	7,380,000	5,711,000	6,745,000	5,948,000	6,102,000	4,604,000	3,883,000	3,303,000	3,697,000	4,633,000	4,434,000	2,831,000	6,842,000	5,673,000	6,273,000	2,728,000	2,427,000	2,489,000	3,858,000	3,478,000	4,058,000	3,578,000	4,978,000	2,323,000	1,375,000	1,120,000	1,241,000	1,217,000	2,052,000	2,419,000	4,145,000	1,868,000	1,130,000	1,393,000	1,788,000	1,515,000	1,360,000	1,079,000	817,000	802,000	586,000	1,008,000	1,231,000	1,098,000	991,000	1,351,000	5,138,000	5,205,000	6,049,000	3,529,000	1,760,000	1,682,000	673,000	1,117,000	1,275,000	2,704,000	1,277,000	1,806,000	2,136,000	2,117,000	1,396,000	1,043,000	930,000
total current assets	785,712,000	815,970,000	848,941,000	926,241,000	882,012,000	851,286,000	859,120,000	835,666,000	797,460,000	830,141,000	916,985,000	932,944,000	955,405,000	940,515,000	972,520,000	852,670,000	583,906,000	427,533,000	290,015,000	290,003,000	265,466,000	194,147,000	208,653,000	228,835,000	191,450,000	222,524,000	174,364,000	198,784,000	226,342,000	255,396,000	198,023,000	197,096,000	132,205,000	89,652,000	89,599,000	117,514,000	147,126,000	170,739,000	199,946,000	224,349,000	97,896,000	101,981,000	127,437,000	134,877,000	160,583,000	181,732,000	192,378,000	79,753,000	92,427,000	108,137,000	128,187,000	154,383,000	165,628,000	110,124,000	124,618,000	55,397,000	64,651,000	55,845,000	74,515,000	50,224,000	60,177,000	32,690,000	38,882,000	49,301,000	56,457,000	65,218,000	76,542,000	72,502,000	77,009,000	85,167,000	101,939,000	73,499,000	86,096,000	74,886,000	89,686,000	62,331,000	63,140,000	71,024,000	77,484,000	54,004,000	61,522,000	68,906,000	70,779,000	76,509,000	79,538,000
property and equipment	45,610,000	43,272,000	39,001,000	37,420,000	36,105,000	36,413,000	37,297,000	36,183,000	37,442,000	38,159,000	37,596,000	35,352,000	36,286,000	36,407,000	35,020,000	34,251,000	32,547,000	30,696,000	30,567,000	30,379,000	30,476,000	30,897,000	32,022,000	31,461,000	34,393,000	25,305,000	17,064,000	16,933,000	16,240,000	17,064,000	16,619,000	16,622,000	16,751,000	16,633,000	17,174,000	18,739,000	17,448,000	15,894,000	13,804,000	11,606,000	8,887,000	7,528,000	7,924,000	8,129,000	8,789,000	8,584,000	8,706,000	8,454,000	8,038,000	7,972,000	7,965,000	6,948,000	6,833,000	6,962,000	6,163,000	6,127,000	6,570,000	6,516,000	6,404,000	6,634,000	6,324,000	7,199,000	7,997,000	8,507,000	8,610,000	8,600,000	9,510,000	10,241,000	11,165,000	10,268,000	7,314,000	6,380,000	6,040,000	5,552,000	5,200,000	4,918,000	4,986,000	2,035,000	2,197,000	2,286,000	2,405,000	2,344,000	2,465,000	2,157,000	1,065,000
operating lease right-of-use assets	20,314,000	20,869,000	21,608,000	21,780,000	22,526,000	23,392,000	24,287,000	24,949,000	25,366,000	25,433,000	25,745,000	25,680,000	25,785,000	26,310,000	25,964,000	26,772,000	25,164,000	25,799,000	26,583,000	27,353,000	27,871,000	28,436,000	30,252,000	29,723,000	29,533,000	33,505,000
goodwill	2,200,000	2,027,000	1,946,000	2,091,000	2,007,000	2,022,000	2,067,000	1,981,000	2,039,000	2,038,000	2,006,000	1,835,000	1,958,000	2,082,000	2,125,000	2,171,000	2,225,000	2,197,000	2,297,000	2,196,000	2,103,000	2,061,000	2,081,000	2,045,000	2,131,000	2,102,000	2,144,000	2,174,000	2,189,000	2,309,000	2,244,000	2,213,000	2,140,000	2,001,000	1,971,000	2,100,000	2,080,000	2,127,000	2,043,000	2,106,000	2,078,000	2,032,000	2,277,000	2,376,000	2,557,000	2,576,000	2,579,000	2,532,000	2,436,000	2,400,000	2,475,000	2,408,000	2,356,000	2,498,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000	2,312,000
other assets, net of allowance for doubtful accounts of 10,970 at june 30, 2025	64,613,000
total assets	918,449,000	945,928,000	986,256,000	1,061,990,000	1,016,321,000	986,565,000	997,096,000	972,933,000	936,432,000	969,922,000	985,850,000	999,337,000	1,022,999,000	1,008,975,000	1,039,246,000	919,711,000	647,909,000	490,119,000	353,272,000	353,395,000	329,314,000	259,256,000	279,068,000	301,015,000	267,081,000	296,600,000	210,884,000	236,388,000	263,863,000	295,333,000	218,785,000	217,827,000	151,968,000	110,132,000	109,680,000	139,298,000	167,613,000	189,644,000	216,633,000	238,907,000	109,494,000	112,169,000	138,290,000	146,896,000	173,465,000	193,585,000	204,622,000	91,698,000	104,012,000	119,621,000	139,752,000	164,822,000	175,895,000	120,676,000	134,102,000	64,719,000	74,430,000	65,507,000	84,249,000	61,790,000	71,678,000	44,284,000	50,470,000	61,644,000	69,148,000	78,144,000	90,623,000	87,559,000	96,938,000	105,332,000	120,449,000	87,996,000	98,482,000	87,033,000	102,890,000	75,498,000	76,624,000	73,471,000	80,093,000	56,702,000	64,339,000	71,250,000	73,646,000	79,073,000	81,014,000
liabilities and stockholders’ equity
current liabilities:
accounts payable	2,702,000	4,330,000	9,061,000	7,089,000	4,555,000	2,431,000	5,245,000	3,120,000	3,246,000	7,296,000	3,211,000	3,050,000	4,959,000	20,194,000	2,600,000	3,596,000	12,079,000	3,154,000	3,312,000	5,273,000	2,695,000	4,557,000	9,278,000	7,660,000	11,226,000	11,868,000	5,278,000	4,089,000	3,314,000	2,279,000	4,539,000	2,243,000	681,000	1,466,000	3,796,000	3,795,000	4,486,000	3,476,000	3,433,000	2,359,000	2,345,000	3,272,000	1,159,000	4,972,000	1,900,000	1,863,000	1,901,000	1,289,000	1,253,000	1,727,000	2,166,000	1,578,000	1,155,000	2,358,000	2,040,000	1,313,000	1,742,000	1,880,000	2,329,000	2,067,000	1,033,000	1,091,000	1,686,000	1,037,000	1,222,000	1,088,000	905,000	1,130,000	1,379,000	2,764,000	4,418,000	1,951,000	3,405,000	1,564,000	2,181,000	3,108,000	1,417,000	896,000	952,000	2,259,000	1,620,000	729,000	1,391,000	2,059,000	2,161,000
accrued research and development	5,459,000	5,654,000	4,310,000	4,402,000	4,581,000	3,137,000	2,982,000	3,290,000	3,594,000	5,155,000	4,775,000	4,300,000	3,678,000	6,359,000	4,688,000	3,935,000	4,167,000	2,890,000	2,805,000	2,939,000	2,396,000	3,253,000	4,120,000	4,242,000	5,501,000	9,630,000	9,714,000	6,003,000	4,121,000	4,443,000	4,359,000	3,079,000	3,223,000	4,305,000	5,048,000	4,702,000	5,273,000	6,027,000	7,361,000	7,861,000	5,927,000	7,346,000	6,938,000	6,801,000	6,720,000
accrued liabilities	65,952,000	54,292,000	61,066,000	54,102,000	48,488,000	45,841,000	49,448,000	43,462,000	33,872,000	27,833,000	30,719,000	38,209,000	34,146,000	16,108,000	49,796,000	87,910,000	25,711,000	16,083,000	19,099,000	17,192,000	13,181,000	12,268,000	14,802,000	17,003,000	19,550,000	12,384,000	16,041,000	14,506,000	11,087,000	9,820,000	9,695,000	7,567,000	7,184,000	6,607,000	11,192,000	21,988,000	18,464,000	13,251,000	15,337,000	5,952,000	4,746,000	3,593,000	6,317,000			6,608,000	8,166,000	8,148,000	7,307,000	8,166,000	10,063,000	9,163,000	7,340,000	6,301,000	8,159,000	7,316,000	7,113,000	8,158,000	10,943,000	17,530,000	14,644,000	10,571,000	7,507,000	7,356,000	6,682,000	6,878,000	6,816,000	11,976,000	10,381,000	10,267,000	12,059,000	11,075,000	9,636,000	9,788,000	10,742,000	6,930,000	6,195,000	4,709,000	3,841,000	3,910,000	4,549,000	4,240,000	4,371,000	4,885,000	3,235,000
convertible notes, current portion, net of debt discount of 188 at june 30, 2025	40,020,000
other current liabilities	4,097,000	4,103,000	4,197,000	4,437,000	4,568,000	4,593,000	4,520,000	4,392,000	4,150,000	3,830,000	3,631,000	3,388,000	3,047,000	2,969,000	2,590,000	2,889,000	3,489,000	3,356,000	3,247,000	8,849,000	3,045,000	2,951,000	9,987,000	9,849,000	8,296,000	8,369,000	7,000,000	7,000,000	7,000,000	7,000,000
total current liabilities	118,230,000	68,379,000	78,634,000	70,030,000	62,192,000	56,002,000	62,195,000	54,264,000	44,862,000	91,515,000	150,074,000	244,080,000	345,198,000	466,203,000	556,402,000	528,935,000	204,642,000	109,422,000	77,411,000	66,625,000	53,222,000	29,279,000	53,047,000	46,348,000	44,573,000	42,251,000	38,033,000	31,598,000	25,522,000	23,542,000	18,593,000	12,889,000	11,088,000	12,378,000	20,036,000	30,485,000	28,223,000	24,513,000	28,785,000	19,730,000	21,964,000	20,499,000	20,279,000	22,820,000	20,183,000	15,982,000	16,192,000	15,563,000	14,906,000	17,060,000	19,014,000	29,365,000	25,259,000	25,817,000	27,219,000	10,058,000	10,284,000	11,467,000	14,701,000	21,026,000	29,135,000	16,361,000	14,478,000	11,520,000	11,576,000	24,120,000	40,854,000	19,890,000	15,442,000	16,547,000	19,904,000	13,807,000	13,589,000	12,100,000	13,701,000	11,465,000	8,441,000	6,355,000	5,543,000	6,169,000	6,217,000	4,969,000	6,762,000	8,694,000	7,146,000
convertible notes, net of debt discount of 4,248 and 1,646 at june 30, 2025 and december 31, 2024, respectively	220,752,000
long-term portion of lease liabilities	24,726,000	25,521,000	26,388,000	26,607,000	27,473,000	28,559,000	29,720,000	30,680,000	31,545,000	32,131,000	32,801,000	33,127,000	33,677,000	34,253,000	34,316,000	34,929,000	32,897,000	33,795,000	34,789,000	35,519,000	36,231,000	36,972,000	37,845,000	36,964,000	34,641,000	35,076,000
cepi accrual long-term	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000	60,337,000
other long-term liabilities	242,000	243,000	244,000	28,000	198,000	203,000	74,000	321,000	349,000	352,000	384,000	251,000	295,000	276,000	5,664,000	79,000	81,000	2,901,000	2,568,000	2,234,000	1,910,000	1,598,000	1,285,000	932,000	643,000	441,000	8,915,000	7,458,000	7,257,000	6,672,000	643,000	504,000	353,000	358,000	443,000	541,000	620,000	700,000	769,000	1,001,000	1,125,000	1,085,000	1,070,000	1,645,000	902,000	927,000	963,000	988,000	627,000	621,000	629,000	624,000	616,000	631,000	617,000	630,000				60,000	65,000	146,000	151,000	160,000	166,000	117,000	101,000	106,000	7,611,000	7,616,000	5,622,000	3,627,000	82,000	99,000	117,000	135,000	152,000	170,000	187,000	205,000	222,000	240,000	258,000
total liabilities	424,287,000	414,987,000	389,457,000	380,563,000	373,472,000	368,085,000	375,024,000	368,017,000	359,227,000	406,190,000	404,837,000	498,761,000	600,200,000	721,491,000	816,872,000	852,135,000	564,529,000	390,357,000	294,579,000	284,111,000	271,019,000	247,432,000	270,778,000	261,859,000	256,493,000	253,441,000	147,819,000	139,375,000	132,550,000	129,446,000	19,236,000	13,393,000	11,441,000	12,736,000	20,479,000	31,026,000	28,843,000	25,213,000	29,554,000	27,719,000	34,966,000	37,096,000	37,808,000	25,320,000	22,795,000	19,732,000	18,328,000	19,302,000	19,353,000	21,694,000	24,926,000	34,764,000
commitments and contingencies
stockholders’ equity:
preferred stock: 0.001 par value, 5,000 shares authorized at june 30, 2025 and december 31, 2024; zero shares outstanding at june 30, 2025 and december 31, 2024
common stock: 0.001 par value, 278,000 shares authorized at june 30, 2025 and december 31, 2024; 117,230 shares and 125,450 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively	117,000
additional paid-in capital	1,474,046,000	1,532,835,000	1,504,671,000	1,591,107,000	1,575,548,000	1,562,027,000	1,554,634,000	1,541,549,000	1,527,544,000	1,516,331,000	1,510,518,000	1,501,639,000	1,484,970,000	1,476,013,000	1,441,868,000	1,386,114,000	1,372,679,000	1,393,947,000	1,352,374,000	1,348,793,000	1,343,279,000	1,245,730,000	1,229,417,000	1,224,228,000	1,161,115,000	1,151,421,000	1,131,241,000	1,124,892,000	1,118,487,000	1,112,321,000	1,107,693,000	1,085,433,000	1,000,177,000	938,159,000	904,957,000	901,075,000	897,027,000	893,278,000	889,698,000	886,575,000	719,966,000	697,149,000	695,058,000	693,066,000	691,419,000	689,729,000	688,390,000	561,687,000	558,766,000	555,010,000	550,729,000	545,767,000	542,934,000	470,849,000	466,276,000	397,996,000	391,925,000	372,105,000	369,686,000	325,492,000	310,756,000	267,583,000	266,127,000	267,115,000	263,806,000	263,135,000	262,579,000	261,862,000	259,843,000	259,068,000	258,266,000	250,770,000	246,358,000	245,669,000	244,787,000	198,809,000	197,620,000	191,099,000	192,840,000	159,173,000	159,126,000	159,120,000	159,074,000	158,691,000	158,473,000
accumulated other comprehensive income	652,000			514,000																																																											-168,000			-794,000	-354,000	-258,000	353,000	502,000	398,000	248,000	187,000	158,000	172,000
accumulated deficit	-980,653,000	-999,374,000	-903,275,000	-910,325,000	-927,919,000	-939,305,000	-930,584,000	-930,803,000	-945,096,000	-948,527,000	-924,195,000	-991,928,000	-1,055,737,000	-1,184,492,000	-1,217,351,000	-1,317,130,000	-1,288,700,000	-1,293,173,000	-1,294,064,000	-1,278,597,000	-1,282,998,000	-1,231,419,000	-1,218,824,000	-1,182,068,000	-1,148,609,000	-1,105,896,000	-1,066,224,000	-1,026,255,000	-985,727,000	-946,283,000	-907,325,000	-879,904,000	-857,776,000	-837,458,000	-812,171,000	-790,430,000	-755,736,000	-726,750,000	-699,727,000	-672,865,000	-642,741,000	-619,150,000	-592,933,000	-570,647,000	-540,828,000	-516,051,000	-502,211,000	-489,155,000	-473,480,000	-456,316,000	-435,491,000	-414,948,000	-397,157,000	-382,047,000	-365,542,000	-361,275,000	-346,046,000	-335,411,000	-316,945,000	-301,823,000	-296,825,000	-268,821,000	-259,637,000	-249,038,000	-239,532,000	-243,642,000	-248,743,000	-251,842,000	-246,422,000	-240,343,000	-227,914,000	-215,838,000	-198,737,000	-181,033,000	-167,943,000	-151,488,000	-139,336,000	-124,063,000	-115,891,000	-107,129,000	-98,845,000	-90,266,000	-95,336,000	-90,173,000	-86,140,000
total stockholders’ equity	494,162,000	530,941,000	596,799,000	681,427,000	642,849,000	618,480,000	622,072,000	604,916,000	577,205,000	563,732,000	581,013,000	500,576,000	422,799,000	287,484,000	222,374,000	67,576,000	83,380,000	99,762,000	58,693,000	69,284,000	58,295,000	11,824,000	8,290,000	39,156,000	10,588,000	43,159,000	63,065,000	97,013,000	131,313,000	165,887,000	199,549,000	204,434,000	140,527,000	97,396,000	89,201,000	108,272,000	138,770,000	164,431,000	187,079,000	211,188,000	74,528,000	75,073,000	100,482,000	121,576,000	150,670,000	173,853,000	186,294,000	72,396,000	84,659,000	97,927,000	114,826,000	130,058,000	144,708,000	88,379,000	99,880,000	36,229,000	45,830,000	36,495,000	52,111,000	23,208,000	12,808,000	-1,799,000	6,376,000	17,524,000	24,608,000	20,364,000	13,522,000	9,802,000	13,814,000	19,267,000	30,790,000	35,220,000	47,848,000	64,834,000	77,056,000	47,441,000	58,303,000	66,946,000	74,363,000	49,578,000	57,150,000	65,291,000	59,876,000	64,129,000	67,368,000
total liabilities and stockholders’ equity	918,449,000	945,928,000	986,256,000	1,061,990,000	1,016,321,000	986,565,000	997,096,000	972,933,000	936,432,000	969,922,000	985,850,000	999,337,000	1,022,999,000	1,008,975,000	1,039,246,000	919,711,000	647,909,000	490,119,000	353,272,000	353,395,000	329,314,000	259,256,000	279,068,000	301,015,000	267,081,000	296,600,000	210,884,000	236,388,000	263,863,000	295,333,000	218,785,000	217,827,000	151,968,000	110,132,000	109,680,000	139,298,000	167,613,000	189,644,000	216,633,000	238,907,000	109,494,000	112,169,000	138,290,000	146,896,000	173,465,000	193,585,000	204,622,000	91,698,000	104,012,000	119,621,000	139,752,000	164,822,000	175,895,000	120,676,000	134,102,000	64,719,000	74,430,000	65,507,000	84,249,000	61,790,000	71,678,000	44,284,000	50,470,000	61,644,000	69,148,000	78,144,000									102,890,000			73,471,000	80,093,000	56,702,000	64,339,000	71,250,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at march 31, 2025 and december 31, 2024, respectively		54,925,000
other assets, net of allowance for doubtful accounts of 10,970 at march 31, 2025		63,790,000
convertible notes, net of debt discount of 4,701 and 1,646 at march 31, 2025 and december 31, 2024, respectively		260,507,000
preferred stock: 0.001 par value, 5,000 shares authorized at march 31, 2025 and december 31, 2024; zero shares outstanding at march 31, 2025 and december 31, 2024
common stock: 0.001 par value, 278,000 shares authorized at march 31, 2025 and december 31, 2024; 123,697 shares and 125,450 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively		124,000
accumulated other comprehensive loss		-2,644,000	-4,722,000		-4,911,000	-4,373,000	-2,108,000	-5,959,000	-5,372,000	-4,200,000	-5,438,000	-9,262,000	-6,560,000	-4,163,000						-1,022,000	-2,095,000	-2,575,000	-2,387,000	-3,088,000	-1,983,000	-2,431,000	-2,015,000	-1,687,000	-1,510,000	-213,000	-881,000	-1,156,000	-1,929,000	-3,350,000	-3,624,000	-2,412,000	-2,559,000	-2,135,000	-2,930,000	-2,560,000	-2,727,000	-2,955,000	-1,669,000	-1,106,000	-184,000															-549,000	-1,210,000	-616,000		-36,000	-348,000												-12,000	-120,000					-102,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at december 31, 2024 and december 31, 2023, respectively			45,281,000
other assets			74,760,000	74,458,000	73,671,000	73,452,000	74,325,000	74,154,000	73,915,000	73,941,000	3,311,000	3,337,000	3,363,000	3,447,000	3,398,000	3,623,000	3,838,000	3,668,000	3,573,000	3,238,000	3,181,000	3,301,000	3,344,000	3,509,000	1,799,000	3,104,000	4,976,000	3,834,000	2,104,000	1,267,000	1,270,000	1,270,000	253,000	1,241,000	334,000	330,000	346,000	267,000	231,000	231,000	20,000	20,000	20,000	872,000	876,000	31,000	297,000	302,000	463,000	468,000	473,000	438,000	438,000	438,000	362,000	224,000	224,000	112,000	67,000	2,076,000	2,076,000	1,049,000							3,703,000	4,591,000	5,645,000	2,178,000	155,000	153,000	1,310,000	1,304,000	1,302,000	412,000	412,000	412,000	412,000		402,000	407,000	411,000
convertible notes, net of debt discount of 1,646 and 2,802 at december 31, 2024 and december 31, 2023, respectively			223,854,000
preferred stock: 0.001 par value, 5,000 shares authorized at december 31, 2024, and 2023; zero shares outstanding at december 31, 2024 and 2023
common stock: 0.001 par value; 278,000 shares authorized at december 31, 2024 and 2023; 125,450 shares and 129,530 shares issued and outstanding at december 31, 2024 and 2023, respectively			125,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at september 30, 2024 and december 31, 2023, respectively				73,334,000
convertible notes, net of debt discount of 1,939 and 2,802 at september 30, 2024 and december 31, 2023, respectively				223,561,000
preferred stock: 0.001 par value, 5,000 shares authorized at september 30, 2024 and december 31, 2023; zero shares outstanding at september 30, 2024 and december 31, 2023
common stock: 0.001 par value, 278,000 shares authorized at september 30, 2024 and december 31, 2023; 131,345 shares and 129,530 shares issued and outstanding at september 30, 2024 and december 31, 2023, respectively				131,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at june 30, 2024 and december 31, 2023, respectively					61,654,000
convertible notes, net of debt discount of 2,228 and 2,802 at june 30, 2024 and december 31, 2023, respectively					223,272,000
preferred stock: 0.001 par value, 5,000 shares authorized at june 30, 2024 and december 31, 2023; zero shares outstanding at june 30, 2024 and december 31, 2023
common stock: 0.001 par value, 278,000 shares authorized at june 30, 2024 and december 31, 2023; 130,984 shares and 129,530 shares issued and outstanding at june 30, 2024 and december 31, 2023, respectively					131,000
accounts receivables, net of allowance for doubtful accounts of 12,313 at march 31, 2024 and december 31, 2023, respectively						44,161,000
convertible notes, net of debt discount of 2,516 and 2,802 at march 31, 2024 and december 31, 2023, respectively						222,984,000
preferred stock: 0.001 par value, 5,000 shares authorized at march 31, 2024 and december 31, 2023; zero shares outstanding at march 31, 2024 and december 31, 2023
common stock: 0.001 par value, 278,000 shares authorized at march 31, 2024 and december 31, 2023; 130,859 shares and 129,530 shares issued and outstanding at march 31, 2024 and december 31, 2023, respectively						131,000
accounts receivables, net of allowance for doubtful accounts of 12,313 and 0 at december 31, 2023 and december 31, 2022, respectively							40,607,000
cepi accrual										47,401,000	107,738,000	107,738,000	107,370,000	107,370,000	128,848,000
convertible notes, net of debt discount of 2,802 and 3,922 at december 31, 2023 and december 31, 2022, respectively							222,698,000
preferred stock: 0.001 par value, 5,000 shares authorized at december 31, 2023, and 2022; zero shares outstanding at december 31, 2023 and 2022
common stock: 0.001 par value; 278,000 shares authorized at december 31, 2023 and 2022; 129,530 shares and 127,604 shares issued and outstanding at december 31, 2023 and 2022, respectively							130,000
accounts receivables, net of allowance for doubtful accounts of 12,313 and 0 at september 30, 2023 and december 31, 2022, respectively								46,347,000
convertible notes, net of debt discount of 3,085 and 3,922 at september 30, 2023 and december 31, 2022, respectively								222,415,000
preferred stock: 0.001 par value; 5,000 shares authorized at september 30, 2023 and december 31, 2022; zero shares outstanding at september 30, 2023 and december 31, 2022, respectively
common stock: 0.001 par value; 278,000 shares authorized at september 30, 2023 and december 31, 2022; 129,195 shares and 127,604 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively								129,000
accounts receivables, net of allowance for doubtful accounts of 12,313 and 0 at june 30, 2023 and december 31, 2022, respectively									43,245,000
restricted cash									210,000	210,000	207,000	189,000	202,000	214,000	219,000	224,000	229,000	226,000	237,000	226,000	217,000	212,000	216,000	619,000	628,000	615,000	619,000	622,000	624,000	635,000	629,000	626,000	619,000	605,000	602,000	615,000	613,000	617,000	609,000	615,000	613,000	608,000	632,000	642,000	660,000	662,000	662,000	657,000	648,000	644,000	652,000	645,000	640,000	654,000	647,000	659,000	673,000	668,000	652,000	659,000	633,000	656,000	681,000	677,000	667,000	651,000	668,000	674,000	699,000	661,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	408,000	77,000
convertible notes, net of debt discount of 3,366 and 3,922 at june 30, 2023 and december 31, 2022, respectively									222,134,000
preferred stock: 0.001 par value; 5,000 shares authorized at june 30, 2023 and december 31, 2022; zero shares outstanding at june 30, 2023 and december 31, 2022, respectively
common stock: 0.001 par value; 278,000 shares authorized at june 30, 2023 and december 31, 2022; 128,779 shares and 127,604 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively									129,000
accounts receivables, net of allowance for doubtful accounts of 12,313 and 0 at march 31, 2023 and december 31, 2022, respectively										101,738,000
convertible notes, net of debt discount of 3,645 and 3,922 at march 31, 2023 and december 31, 2022, respectively										221,855,000
preferred stock: 0.001 par value; 5,000 shares authorized at march 31, 2023 and december 31, 2022; zero shares outstanding at march 31, 2023 and december 31, 2022, respectively
common stock: 0.001 par value; 278,000 shares authorized at march 31, 2023 and december 31, 2022; 128,472 shares and 127,604 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively										128,000
accounts receivables											145,130,000	129,772,000	172,270,000	133,968,000	116,216,000
prepaid manufacturing												12,727,000	54,477,000	138,330,000	159,655,000	109,763,000	36,298,000	32,642,000	29,423,000
warrant liability															18,016,000	72,017,000	29,639,000	31,737,000	10,736,000	10,660,000	31,905,000	6,250,000	14,860,000	7,594,000
deferred revenue												87,395,000	191,998,000	313,203,000	349,864,000	358,588,000	129,557,000	52,202,000	38,212,000	21,712,000																																																																1,750,000
convertible notes, net of debt discount of 3,922 and 5,010 at december 31, 2022 and december 31, 2021, respectively											221,578,000
preferred stock: 0.001 par value, 5,000 shares authorized at december 31, 2022, and 2021; zero shares outstanding at december 31, 2022 and 2021
common stock: 0.001 par value; 278,000 shares authorized at december 31, 2022 and 2021; 127,604 shares and 122,945 shares issued and outstanding at december 31, 2022 and 2021, respectively											128,000
convertible notes, net of debt discount of 4,197 and 5,010 at september 30, 2022, and december 31, 2021, respectively												221,303,000
common stock: 0.001 par value; 278,000 shares authorized at september 30, 2022 and december 31, 2021; 127,581 shares and 122,945 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively												127,000
convertible notes, net of debt discount of 4,470 and 5,010 at june 30, 2022 and december 31, 2021, respectively													221,030,000
common stock: 0.001 par value; 278,000 shares authorized at june 30, 2022 and december 31, 2021; 126,439 shares and 122,945 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively													126,000
convertible notes, net of debt discount of 4,741 and 5,010 at march 31, 2022 and december 31, 2021, respectively														220,759,000
common stock: 0.001 par value; 278,000 shares authorized at march 31, 2022 and december 31, 2021; 126,297 shares and 122,945 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively														126,000
long-term debt, net of debt discount of 1,094 at december 31, 2020
convertible notes, net of debt discount of 5,010 at december 31, 2021															220,490,000
preferred stock: 0.001 par value
authorized: 5,000 shares; issued and outstanding:
series b convertible preferred stock — no shares and 4 shares at december 31, 2021 and 2020, respectively
common stock: 0.001 par value; 278,000 shares authorized at december 31, 2021 and 2020; 122,945 shares and 110,190 shares issued and outstanding at december 31, 2021 and 2020, respectively															123,000
accumulated other comprehensive gain															-2,266,000	-1,528,000	-713,000	-1,126,000	273,000																																																									89,000
accounts and other receivables																200,362,000	105,900,000	83,994,000	22,661,000	35,023,000	903,000	8,135,000	8,886,000	8,822,000	7,582,000	5,791,000	3,704,000	1,507,000	1,304,000	763,000	854,000	783,000	810,000	1,465,000	1,342,000	2,290,000	1,864,000
convertible notes, net of debt discount of 5,277 at september 30, 2021																220,223,000
long-term deferred revenue																67,969,000	106,950,000	64,350,000
series b convertible preferred stock ̶ no shares and 4 shares at september 30, 2021 and december 31, 2020, respectively
common stock: 0.001 par value; 278,000 shares authorized at september 30, 2021 and december 31, 2020; 119,787 shares and 110,190 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively																120,000
convertible notes, net of debt discount of 5,541 at june 30, 2021																	219,959,000
series b convertible preferred stock ̶ 4 shares at june 30, 2021 and december 31, 2020
common stock: 0.001 par value; 278,000 shares authorized at june 30, 2021 and december 31, 2020; 114,756 shares and 110,190 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively																	114,000
long-term debt, net of debt discount of 1,016 and 1,094 at march 31, 2021 and december 31, 2020, respectively																		179,889,000
series b convertible preferred stock ̶ 4 shares at march 31, 2021 and december 31, 2020
common stock: 0.001 par value; 278,000 shares authorized at march 31, 2021 and december 31, 2020; 114,563 shares and 110,190 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively																		114,000
intangible assets																						202,000	2,500,000	4,823,000	7,147,000	9,445,000	11,717,000	14,041,000	16,364,000	18,662,000	1,306,000
long-term debt, net of debt discount of 1,094 and 1,394 at december 31, 2020 and 2019, respectively																			179,811,000
series b convertible preferred stock — 4 shares and 5 shares at december 31, 2020 and 2019, respectively
common stock: 0.001 par value; 278,000 shares and 139,000 shares authorized at december 31, 2020 and 2019, respectively; 110,190 shares and 83,871 shares issued and outstanding at december 31, 2020 and 2019, respectively																			110,000
long-term debt, net of debt discount of 1,172 and 1,394 at september 30, 2020 and december 31, 2019, respectively																				179,733,000
series b convertible preferred stock ̶ 4 shares and 5 shares at september 30, 2020 and december 31, 2019, respectively
common stock: 0.001 par value; 278,000 shares and 139,000 shares authorized at september 30, 2020 and december 31, 2019, respectively; 110,173 shares and 83,871 shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively																				110,000
long-term debt, net of debt discount of 1,248 and 1,394 at june 30, 2020 and december 31, 2019, respectively																					179,656,000
series b convertible preferred stock ̶ 4 shares and 5 shares at june 30, 2020 and december 31, 2019, respectively
common stock: 0.001 par value; 278,000 shares and 139,000 shares authorized at june 30, 2020 and december 31, 2019, respectively; 109,503 shares and 83,871 shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively																					109,000
long-term debt																						179,583,000	178,601,000	177,615,000	176,636,000	175,673,000		100,319,000	99,771,000	99,232,000												8,913,000
series b convertible preferred stock ̶ 5 shares at march 31, 2020 and december 31, 2019
common stock: 0.001 par value; 139,000 shares authorized at march 31, 2020 and december 31, 2019; 87,599 and 83,871 shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively																						88,000
series b convertible preferred stock — 5 shares at december 31, 2019 and no shares at december 31, 2018
common stock: 0.001 par value; 139,000 shares authorized at december 31, 2019 and 2018; 83,871 and 62,862 shares issued and outstanding at december 31, 2019 and 2018, respectively																							84,000
series b convertible preferred stock ̶ 5 shares at september 30, 2019 and no shares at december 31, 2018
common stock: 0.001 par value; 139,000 shares authorized at september 30, 2019 and december 31, 2018; 83,865 and 62,862 shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively																								84,000
preferred stock: 0.001 par value; 5,000 shares authorized at june 30, 2019 and december 31, 2018; no shares issued and outstanding at june 30, 2019 and december 31, 2018
common stock: 0.001 par value; 139,000 shares authorized at june 30, 2019 and december 31, 2018; 65,155 and 62,862 shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively																									65,000
preferred stock: 0.001 par value; 5,000 shares authorized at march 31, 2019 and december 31, 2018; no shares issued and outstanding at march 31, 2019 and december 31, 2018
common stock: 0.001 par value; 139,000 shares authorized at march 31, 2019 and december 31, 2018; 65,020 and 62,862 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively																										65,000
long term debt																											100,871,000																9,559,000
preferred stock: 0.001 par value; 5,000 shares authorized at december 31, 2018 and december 31, 2017; no shares issued and outstanding at december 31, 2018 and december 31, 2017
common stock: 0.001 par value; 139,000 shares authorized at december 31, 2018 and 2017; 62,862 and 61,533 shares issued and outstanding at december 31, 2018 and 2017, respectively																											63,000
preferred stock: 0.001 par value; 5,000 shares authorized at september 30, 2018 and december 31, 2017; no shares issued and outstanding at september 30, 2018 and december 31, 2017
common stock: 0.001 par value; 139,000 shares authorized at september 30, 2018 and december 31, 2017; 62,691 and 61,533 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively																												63,000
preferred stock: 0.001 par value; 5,000 shares authorized at june 30, 2018 and december 31, 2017; no shares issued and outstanding at june 30, 2018 and december 31, 2017
common stock: 0.001 par value; 139,000 shares authorized at june 30, 2018 and december 31, 2017; 62,608 and 61,533 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively																													63,000
preferred stock: 0.001 par value; 5,000 shares authorized at march 31, 2018 and december 31, 2017; no shares issued and outstanding at march 31, 2018 and december 31, 2017
common stock: 0.001 par value; 139,000 shares authorized at march 31, 2018 and december 31, 2017; 62,254 and 61,533 shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively																														62,000
preferred stock: 0.001 par value; 5,000 shares authorized at december 31, 2017 and december 31, 2016; no shares issued and outstanding at december 31, 2017 and december 31, 2016
common stock: 0.001 par value; 139,000 and 69,500 shares authorized at december 31, 2017 and 2016, respectively; 61,533 and 38,599 shares issued and outstanding at december 31, 2017 and 2016, respectively																															62,000
preferred stock: 0.001 par value; 5,000 shares authorized at september 30, 2017 and december 31, 2016; no shares issued and outstanding at september 30, 2017 and december 31, 2016
common stock: 0.001 par value; 139,000 and 69,500 shares authorized at september 30, 2017 and december 31, 2016, respectively; 60,587 and 38,599 shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively																																61,000
preferred stock: 0.001 par value; 5,000 shares authorized at june 30, 2017 and december 31, 2016; no shares issued and outstanding at june 30, 2017 and december 31, 2016
common stock: 0.001 par value; 139,000 and 69,500 shares authorized at june 30, 2017 and december 31, 2016, respectively; 54,748 and 38,599 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively																																	55,000
preferred stock: 0.001 par value; 5,000 shares authorized at march 31, 2017 and december 31, 2016; no shares issued and outstanding at march 31, 2017 and december 31, 2016
common stock: 0.001 par value; 69,500 shares authorized at march 31, 2017 and december 31, 2016; 45,448 and 38,599 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively																																		45,000
deferred revenues																																						1,759,000	2,654,000	3,558,000	7,448,000	5,694,000	5,865,000	5,644,000	6,584,000	7,511,000	6,125,000	6,126,000	6,346,000	7,167,000	6,785,000	4,172,000	2,859,000	3,801,000	4,210,000	1,429,000	1,429,000	1,429,000	1,429,000	1,429,000	1,429,000	2,384,000	2,718,000	3,127,000	3,672,000	16,154,000	33,133,000	6,784,000	3,682,000	3,516,000	3,427,000	781,000	548,000	748,000	778,000	1,427,000	829,000	750,000	750,000		48,000		1,000,000
preferred stock: 0.001 par value; 5,000 shares authorized at december 31, 2016 and december 31, 2015; no shares issued and outstanding at december 31, 2016 and december 31, 2015
common stock: 0.001 par value; 69,500 shares authorized at december 31, 2016 and 2015; 38,599 and 38,446 shares issued and outstanding at december 31, 2016 and 2015, respectively																																			39,000
preferred stock: 0.001 par value; 5,000 shares authorized at september 30, 2016 and december 31, 2015; no shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively
common stock: 0.001 par value; 69,500 shares authorized at september 30, 2016 and december 31, 2015; 38,526 and 38,446 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively																																				39,000
preferred stock: 0.001 par value; 5,000 shares authorized at june 30, 2016 and december 31, 2015; no shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively
common stock: 0.001 par value; 69,500 shares authorized at june 30, 2016 and december 31, 2015; 38,497 and 38,446 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively																																					38,000
accounts receivable																																						1,164,000	1,394,000	1,163,000	657,000	909,000	727,000	727,000	1,292,000	1,730,000	1,627,000	2,159,000	2,025,000	1,547,000	1,005,000	3,685,000	1,284,000	1,375,000	9,527,000	783,000	1,139,000	1,127,000	1,001,000	1,255,000	1,349,000	1,152,000	895,000	1,184,000	1,519,000	2,978,000	6,407,000	6,216,000	8,057,000	6,140,000	7,234,000	574,000	1,102,000	1,218,000	2,154,000	1,885,000	710,000	421,000	689,000	1,061,000	744,000	8,957,000	3,131,000	3,544,000	4,572,000
preferred stock: 0.001 par value; 5,000 shares authorized at march 31, 2016 and december 31, 2015; no shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively
common stock: 0.001 par value; 69,500 shares authorized at march 31, 2016 and december 31, 2015; 38,496 and 38,446 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively																																						38,000
deferred revenues, net of current portion																																								6,988,000	3,916,000	6,599,000	6,900,000	855,000	1,710,000	2,823,000	1,173,000
series b convertible preferred stock — no shares at december 31, 2015 and 43 shares at december 31, 2014
common stock: 0.001 par value; 69,500 shares authorized at december 31, 2015 and 2014, respectively; 38,446 and 26,307 shares issued and outstanding at december 31, 2015 and 2014, respectively																																							38,000
series b convertible preferred stock — no shares and 43 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively
common stock: 0.001 par value; 69,500 shares authorized at september 30, 2015 and december 31, 2014; 38,425 and 26,307 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively																																								38,000
long-term debt, current portion																																									1,498,000	594,000
long-term debt, net of current portion																																									7,961,000
series b convertible preferred stock — 17 shares at june 30, 2015 and 43 at december 31, 2014
common stock: 0.001 par value; 69,500 shares authorized at june 30, 2015 and december 31, 2014; 30,237 and 26,307 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively																																									30,000
series b convertible preferred stock — 17 shares at march 31, 2015 and 43 at december 31, 2014
common stock: 0.001 par value; 69,500 shares authorized at march 31, 2015 and december 31, 2014; 28,926 and 26,307 shares issued and outstanding at march 31, 2015 and december 31, 2014, respectively																																										29,000
series b convertible preferred stock — 43 shares at december 31, 2014 and 2013
common stock: 0.001 par value; 69,500 and 35,000 shares authorized at december 31, 2014 and 2013, respectively; 26,307 and 26,280 shares issued and outstanding at december 31, 2014 and 2013, respectively																																											26,000
other accrued liabilities																																												5,403,000	4,979,000
preferred stock: 0.001 par value:
authorized: 5,000 shares
issued and outstanding: series b convertible preferred stock — 43 shares at september 30, 2014 and december 31, 2013
common stock: 0.001 par value:
authorized: 350,000 shares
issued and outstanding: 262,934 shares at september 30, 2014 and 262,796 shares at december 31, 2013																																												263,000
issued and outstanding: series b convertible preferred stock — 43 shares at june 30, 2014 and december 31, 2013
issued and outstanding: 262,881 shares at june 30, 2014 and 262,796 shares at december 31, 2013																																													263,000
series b convertible preferred stock — 43 shares at march 31, 2014 and december 31, 2013
common stock: 0.001 par value;
issued and outstanding: 262,856 shares at march 31, 2014 and 262,796 shares at december 31, 2013																																														263,000
total accumulated other comprehensive loss																																														-88,000	-148,000	-319,000	-810,000	-950,000	-595,000	-939,000	-1,247,000	-580,000	-1,009,000	-618,000	-172,000	-315,000	-746,000
series b convertible preferred stock — 43 shares at december 31, 2013 and zero shares at december 31, 2012
common stock: 0.001 par value; 350,000 and 250,000 shares authorized at december 31, 2013 and 2012, respectively; 262,796 and 182,792 shares issued and outstanding at december 31, 2013 and 2012, respectively																																															263,000
deferred revenues, noncurrent																																																2,751,000	3,820,000	4,013,000	5,283,000	4,775,000	5,312,000	5,849,000	6,386,000	4,583,000	4,940,000	5,298,000	5,655,000	6,012,000	16,369,000	16,726,000	17,083,000	17,440,000	17,798,000	18,543,000	18,512,000	39,188,000	39,785,000	40,127,000	40,792,000	10,000,000	10,000,000	10,000,000	10,000,000	10,000,000				750,000	750,000	750,000	6,750,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2013 and december 31, 2012
common stock: 0.001 par value; 350,000 and 250,000 shares authorized at september 30, 2013 and december 31, 2012, respectively; 183,055 and 182,792 shares issued and outstanding at september 30, 2013 and december 31, 2012, respectively																																																183,000
accumulated other comprehensive loss:
unrealized gain on marketable securities available-for-sale																																																22,000	4,000	37,000	45,000	29,000			-3,000		2,000	9,000	-17,000						1,000	17,000	49,000		24,000	182,000	138,000	23,000	35,000	16,000	28,000	7,000
cumulative translation adjustment																																																-341,000	-814,000	-987,000	-640,000	-968,000	-1,217,000	-577,000	-1,006,000	-612,000	-174,000	-324,000	-729,000	-552,000	-1,220,000	-616,000	-168,000	-36,000	-349,000	-811,000	-403,000	-273,000	329,000	320,000	260,000	225,000	152,000	142,000	144,000	82,000	60,000	-5,000		-4,000	-4,000	-4,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2013 and december 31, 2012
common stock: 0.001 par value; 350,000 and 250,000 shares authorized at june 30, 2013 and december 31, 2012, respectively; 182,988 and 182,792 shares issued and outstanding at june 30, 2013 and december 31, 2012, respectively																																																	183,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2013 and december 31, 2012
common stock: 0.001 par value; 250,000 shares authorized at march 31, 2013 and december 31, 2012; 182,886 and 182,792 shares issued and outstanding at march 31, 2013 and december 31, 2012, respectively																																																		183,000
note payable to symphony dynamo holdings llc																																																				14,452,000	13,905,000	13,357,000	12,810,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2012 and 2011
common stock: 0.001 par value; 250,000 shares authorized at december 31, 2012 and 2011, respectively; 182,792 and 154,626 shares issued and outstanding at december 31, 2012 and 2011, respectively																																																			183,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2012 and december 31, 2011
common stock: 0.001 par value; 250,000 shares authorized; 178,270 and 154,626 shares issued and outstanding at september 30, 2012 and december 31, 2011, respectively																																																				178,000
dynavax stockholders’ equity:
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2012 and december 31, 2011
common stock: 0.001 par value; 250,000 shares authorized; 177,729 and 154,626 shares issued and outstanding at june 30, 2012 and december 31, 2011, respectively																																																					178,000
unrealized loss on marketable securities available-for-sale																																																					-30,000	-3,000		-6,000																					-72,000	-115,000		-96,000	-120,000	-161,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2012 and december 31, 2011
common stock: 0.001 par value; 250,000 shares authorized at march 31, 2012 and december 31, 2011; 156,631 and 154,626 shares issued and outstanding at march 31, 2012 and december 31, 2011, respectively																																																						157,000
marketable securities																																																							82,020,000	34,149,000	34,245,000	32,232,000	49,701,000	19,022,000	28,325,000				6,509,000	13,783,000	15,264,000				42,324,000				58,677,000	25,243,000	31,613,000	50,649,000		31,561,000	53,118,000	46,023,000
other intangible assets																																																								0		54,000	299,000	544,000	789,000	1,034,000	1,279,000	1,524,000	1,769,000	2,014,000	2,259,000	2,504,000	2,749,000	2,994,000	3,239,000	3,627,000	3,879,000	4,130,000	4,382,000	4,633,000	4,884,000
long-term note payable to holdings																																																											10,939,000	10,540,000	10,140,000	9,741,000	9,342,000
long-term contingent liability to holdings																																																								877,000			843,000	944,000	3,161,000	3,109,000	3,040,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2011 and 2010
common stock: 0.001 par value; 250,000 and 150,000 shares authorized at december 31, 2011 and 2010, respectively; 154,626 and 115,611 shares issued and outstanding at december 31, 2011 and 2010, respectively																																																							155,000
long-term note payable to symphony dynamo holdings llc																																																								12,342,000	11,874,000	11,407,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2011 and december 31, 2010																																																								0
common stock: 0.001 par value; 250,000 and 150,000 shares authorized at september 30, 2011 and december 31, 2010, respectively; 125,611 and 115,611 shares issued and outstanding at september 30, 2011 and december 31, 2010, respectively																																																								126,000
long-term contingent liability to symphony dynamo holdings llc																																																									860,000	840,000
other long-term accrued liabilities																																																									642,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2011 and december 31, 2010
common stock: 0.001 par value; 250,000 and 150,000 shares authorized at june 30, 2011 and december 31, 2010, respectively; 123,418 and 115,611 shares issued and outstanding at june 30, 2011 and december 31, 2010, respectively																																																									123,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2011 and december 31, 2010
common stock: 0.001 par value; 250,000 and 150,000 shares authorized at march 31, 2011 and december 31, 2010, respectively; 116,014 and 115,611 shares issued and outstanding at march 31, 2011 and december 31, 2010, respectively																																																										116,000
warrant liability to symphony dynamo holdings llc																																																													12,029,000	2,315,000	2,567,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2010 and 2009
common stock: 0.001 par value; 150,000 shares authorized at december 31, 2010 and 2009; 115,611 and 54,279 shares issued and outstanding at december 31, 2010 and 2009, respectively																																																											116,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2010 and december 31, 2009
common stock: 0.001 par value; 150,000 shares authorized at september 30, 2010 and december 31, 2009; 88,344 and 54,279 shares issued and outstanding at september 30, 2010 and december 31, 2009, respectively																																																												88,000
unrealized gain on marketable securities available for sale																																																												3,000	10,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2010 and december 31, 2009
common stock: 0.001 par value; 150,000 shares authorized at june 30, 2010 and december 31, 2009; 86,577 and 54,279 shares issued and outstanding at june 30, 2010 and december 31, 2009, respectively																																																													87,000
dynavax stockholders’ equity
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2010 and december 31, 2009
common stock: 0.001 par value; 150,000 shares authorized at march 31, 2010 and december 31, 2009; 55,160 and 54,279 shares issued and outstanding at march 31, 2010 and december 31, 2009, respectively																																																														55,000
investments held by symphony dynamo, inc.																																																																21,697,000	22,772,000	23,788,000	25,109,000	26,685,000	28,029,000	29,475,000	31,631,000	32,804,000	35,098,000	8,609,000	13,363,000	17,727,000	19,044,000
liability from program option exercised under the sdi collaboration																																																																15,000,000	15,000,000	15,000,000	15,000,000	15,000,000	15,000,000	15,000,000	15,000,000	15,000,000	15,000,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2009 and 2008
common stock: 0.001 par value; 150,000 and 100,000 shares authorized at december 31, 2009 and 2008, respectively; 54,279 and 39,854 shares issued and outstanding at december 31, 2009 and 2008, respectively																																																															54,000
accumulated other comprehensive income:
total dynavax stockholders’ equity																																																															6,376,000	18,082,000	23,966,000	18,739,000
noncontrolling interest in sdi																																																																-558,000	642,000	1,625,000	2,634,000	3,573,000	5,286,000	6,775,000	8,341,000	10,342,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2009 and december 31, 2008
common stock: 0.001 par value; 100,000 shares authorized at september 30, 2009 and december 31, 2008; 41,274 and 39,854 shares issued and outstanding at september 30, 2009 and december 31, 2008, respectively																																																																41,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2009 and december 31, 2008
common stock: 0.001 par value; 100,000 shares authorized at june 30, 2009 and december 31, 2008; 39,925 and 39,854 shares issued and outstanding at june 30, 2009 and december 31, 2008, respectively																																																																	40,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2009 and december 31, 2008
common stock: 0.001 par value; 100,000 shares authorized at march 31, 2009 and december 31, 2008; 39,922 and 39,854 shares issued and outstanding at march 31, 2009 and december 31, 2008, respectively																																																																		40,000
liabilities, noncontrolling interest and stockholders’ equity
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2008 and 2007
common stock: 0.001 par value; 100,000 shares authorized at december 31, 2008 and 2007; 39,854 and 39,765 shares issued and outstanding at december 31, 2008 and 2007, respectively																																																																			40,000
total liabilities, noncontrolling interest and stockholders’ equity																																																																			90,623,000	87,559,000	96,938,000	105,332,000	120,449,000	87,996,000	98,482,000	87,033,000		75,498,000	76,624,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2008 and december 31, 2007
common stock: 0.001 par value; 100,000 shares authorized at september 30, 2008 and december 31, 2007; 39,854 and 39,765 shares issued and outstanding at september 30, 2008 and december 31, 2007, respectively																																																																				40,000
unrealized gains on marketable securities available-for-sale																																																																				15,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2008 and december 31, 2007
common stock: 0.001 par value; 100,000 shares authorized at june 30, 2008 and december 31, 2007; 39,806 and 39,765 shares issued and outstanding at june 30, 2008 and december 31, 2007, respectively																																																																					40,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2008 and december 31, 2007
common stock: 0.001 par value; 100,000 shares authorized at march 31, 2008 and december 31, 2007; 39,806 and 39,765 shares issued and outstanding at march 31, 2008 and december 31, 2007, respectively																																																																						40,000
inventory																																																																								263,000	248,000	246,000	257,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2007 and 2006
common stock: 0.001 par value; 100,000 shares authorized at december 31, 2007 and 2006; 39,765 and 39,715 shares issued and outstanding at december 31, 2007 and 2006, respectively																																																																							40,000
commitments and contingencies stockholders’ equity:
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2007 and december 31, 2006
common stock: 0.001 par value; 100,000 shares authorized at september 30, 2007 and december 31, 2006; 39,765 and 39,715 shares issued and outstanding at september 30, 2007 and december 31, 2006, respectively																																																																								40,000
noncontrolling interest in symphony dynamo, inc.																																																																									11,963,000		2,016,000	6,457,000	9,728,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2007 and december 31, 2006
common stock: 0.001 par value; 100,000 shares authorized at june 30, 2007 and december 31, 2006; 39,741 and 39,715 shares issued and outstanding at june 30, 2007 and december 31, 2006, respectively																																																																									40,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2007 and december 31, 2006
common stock: 0.001 par value; 100,000 shares authorized at march 31, 2007 and december 31, 2006; 39,741 and 39,715 shares issued and outstanding at march 31, 2007 and december 31, 2006, respectively																																																																										40,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at december 31, 2006 and 2005
common stock: 0.001 par value; 100,000 shares authorized at december 31, 2006 and 2005; 39,715 and 30,482 shares issued and outstanding at december 31, 2006 and 2005, respectively																																																																											40,000
deferred stock compensation																																																																															-2,467,000	-2,383,000	-2,693,000	-3,029,000	-3,366,000	-3,783,000	-4,369,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2006 and december 31, 2005
common stock: 0.001 par value; 100,000 shares authorized at september 30, 2006 and december 31, 2005; 30,658 and 30,482 shares issued and outstanding at september 30, 2006 and december 31, 2005, respectively																																																																												31,000
accumulated other comprehensive gain:
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2006 and december 31, 2005
common stock: 0.001 par value; 100,000 shares authorized at june 30, 2006 and december 31, 2005; 30,588 and 30,482 shares issued and outstanding at june 30, 2006 and december 31, 2005, respectively																																																																													31,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2006 and december 31, 2005
common stock: 0.001 par value; 100,000 shares authorized at march 31, 2006 and december 31, 2005; 30,495 and 30,482 shares issued and outstanding at march 31, 2006 and december 31, 2005, respectively																																																																														30,000
notes receivable from stockholders																																																																																-8,000	-339,000	-394,000	-419,000	-631,000	-621,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2005 and december 31, 2004
common stock: 0.001 par value; 100,000 shares authorized at september 30, 2005 and december 31, 2004; 24,758 and 24,627 shares issued and outstanding at september 30, 2005 and december 31, 2004, respectively																																																																																25,000
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2005 and december 31, 2004
common stock: 0.001 par value; 100,000 shares authorized at june 30, 2005 and december 31, 2004; 24,748 and 24,627 shares issued and outstanding at june 30, 2005 and december 31, 2004, respectively																																																																																	25,000
liabilities, minority interest, convertible preferred stock, and stockholders’ equity
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at march 31, 2005 and december 31, 2004
common stock: 0.001 par value; 100,000 shares authorized at march 31, 2005 and december 31, 2004; 24,745 and 24,627 shares issued and outstanding at march 31, 2005 and december 31, 2004, respectively																																																																																		25,000
minority interest in dynavax asia
convertible preferred stock: 0.001 par value; no shares authorized at december 31, 2004 and 61,767 shares authorized at december 31, 2003; no shares outstanding at december 31, 2004 and 39,514 shares issued and outstanding at december 31, 2003
stockholders’ equity
total liabilities, minority interest, convertible preferred stock, and stockholders’ equity																																																																																			73,646,000	79,073,000	81,014,000
deferred revenue, noncurrent																																																																																				6,250,000
convertible preferred stock: 0.001 par value; no shares authorized at september 30, 2004 and 61,767 shares authorized at december 31, 2003; no shares outstanding at september 30, 2004 and 39,514 shares outstanding at december 31, 2003
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at september 30, 2004 or december 31, 2003
common stock: 0.001 par value; 100,000 and 28,333 shares authorized at september 30, 2004 and december 31, 2003, respectively; 24,625 and 1,884 shares issued and outstanding at september 30, 2004 and december 31, 2003, respectively																																																																																				25,000
current portion of deferred revenue																																																																																					1,750,000
noncurrent portion of deferred revenue																																																																																					6,500,000
convertible preferred stock
preferred stock: 0.001 par value; 5,000 shares authorized and no shares issued and outstanding at june 30, 2004 or december 31, 2003
common stock: 0.001 par value; 100,000 and 28,333 shares authorized at june 30, 2004 and december 31, 2003, respectively; 24,609 and 1,884 shares issued and outstanding at june 30, 2004 and december 31, 2003, respectively																																																																																					25,000

We provide you with 20 years of balance sheets for Dynavax Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Dynavax Technologies. Explore the full financial landscape of Dynavax Technologies stock with our expertly curated balance sheets.

The information provided in this report about Dynavax Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.